2018 Current Fiscal Year Report: Advisory Committee on Immunization Practices

Transcription

1 2018 Current Fiscal Year Report: Advisory Committee on Immunization Practices Report Run Date: 12/28/ :42:20 PM 1. Department or Agency 2. Fiscal Year Department of Health and Human Services Committee or Subcommittee 3b. GSA Committee No. Advisory Committee on Immunization Practices Is this New During Fiscal Year? 5. Current Charter 6. Expected Renewal Date 7. Expected Term Date No 04/01/ /01/2020 8a. Was Terminated During 8b. Specific Termination FiscalYear? Authority 8c. Actual Term Date No 42 U.S.C. 217a 9. Agency Recommendation for Next FiscalYear 10a. Legislation Req to Terminate? 10b. Legislation Pending? Continue No Not Applicable 11. Establishment Authority Authorized by Law 12. Specific Establishment Authority 13. Effective Date 14. Commitee Type 14c. Presidential? 42 U.S.C. 217a 03/17/1964 Continuing No 15. Description of Committee Scientific Technical Program Advisory Board 16a. Total Number of Reports No Reports for this FiscalYear 17a. Open 3 17b. Closed 0 17c. Partially Closed 0 Other Activities 0 17d. Total 3 Meetings and Dates Purpose Start End The committee is charged with advising the Director, CDC, on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under provisions of the Affordable Care Act, 10/25/ /26/2017 section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been approved by the Director of the Centers for Disease Control and Prevention and appear on CDC immunization schedules must be covered by applicable health plans.

2 The committee is charged with advising the Director, CDC, on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding dosing interval, dosage, and 02/21/ /22/2018 contraindications to administration of vaccines. Further, under provisions of the Affordable Care Act, section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been approved by the Director of the Centers for Disease Control and Prevention and appear on CDC immunization schedules must be covered by applicable health plans. The committee is charged with advising the Director, CDC, on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding dosing interval, dosage, and 06/20/ /21/2018 contraindications to administration of vaccines. Further, under provisions of the Affordable Care Act, section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been approved by the Director of the Centers for Disease Control and Prevention and appear on CDC immunization schedules must be covered by applicable health plans. Current Fiscal Year Next Fiscal Year 18a(1). Personnel Pmts to Non-Federal s $ 21, $ 22, a(2). Personnel Pmts to Federal s $ 0.00 $ a(3). Personnel Pmts to Federal Staff $ 379, $ 342, a(4). Personnel Pmts to Non- Consultants $ 0.00 $ b(1). Travel and Per Diem to Non-Federal s $ 45, $ 52, b(2). Travel and Per Diem to Federal s $ 0.00 $ b(3). Travel and Per Diem to Federal Staff $ 1, $ 1, b(4). Travel and Per Diem to Non-member Consultants $ 0.00 $ c. Other(rents,user charges, graphics, printing, mail, etc.) $ 57, $ 97, d. Total $ 505, $ 517, Federal Staff Support Years (FTE) a. How does the Committee accomplish its purpose?

3 The Advisory Committee on Immunization Practices (ACIP) formulates and updates recommendations on the most appropriate use of vaccines and related agents for the civilian population in the United States, and disseminates this information to assist States and their political subdivisions in the prevention and control of vaccine-preventable diseases. Section of the Omnibus Budget Reconciliation Act of 1993 (OBRA) established a Vaccines for Children (VFC) program. This legislation mandated ACIP to establish a list of vaccines for routine administration to children and adolescents through 18 years of age, along with schedules on the appropriate dosing interval, dose, and contraindications applicable to the pediatric vaccines. This list is used by the Secretary of HHS for the purpose of purchase, delivery, and administration of pediatric vaccines. 20b. How does the Committee balance its membership? During FY18, committee members included experts in the area of use of vaccines and immunologic agents, preventive medicine, epidemiology, infectious diseases, internal medicine, pediatrics, preventive medicine, public health, immunology, and a consumer representative. The racial, ethnic and geographic composition reflects that of the US population; 40% of members are female and 20% of members represent members of racial/ethnic minority groups. Applications are actively solicited from professional organizations representing minority populations. 20c. How frequent and relevant are the Committee Meetings? The committee met three times during FY18. This committee makes vaccine recommendations for FDA licensed vaccines for use in children, adolescents and adults in the United States, regularly evaluates immunization practices in the United States and recommends needed changes, based on evaluation of the risks and benefits of available vaccines and related agents and delivery mechanisms necessary to promote activities in the public and private health sectors. Periodic assessment and revisions are required to the ACIP generated childhood and adult immunization schedules as more data about existing vaccines become available, and as new vaccines become licensed. ACIP continues to address the responsibilities mandated under OBRA. 20d. Why can't the advice or information this committee provides be obtained elsewhere? The committee serves a vitally important role for the U.S. in regularly evaluating the use of vaccines and related agents available for prevention and control of vaccine-preventable diseases in this country to optimize the public health benefits. Its recommendations are based on evaluation of the risks and benefits of vaccines and related agents, and their advice is evidence-based. The committee s responsibilities meet a continuous need for regular review and updating of policies affecting all aspects of evolving immunization practices. There are no existing suitable alternative processes to meet this need.

4 20e. Why is it necessary to close and/or partially closed committee meetings? N/A 21. Remarks No reports required for this committee. Government facilities are used for meetings, eliminating the need for meeting space rental. Caroline Quach replaced Ian Gemmill on 6/9/2017 as NACI liaison and should have been reported in the FY17 report. Richard Gorman 9/15/2011 6/30/2020 Ex-Officio resigned 3/1/2017 Bruce Gellin 9/1/2011 6/30/2020 Ex-Officio resigned 3/1/2017 Designated Federal Officer Amanda Cohn Executive Secretary Committee s Alexander Scott, Nicole Arthur, Phyllis Atmar, Robert Ault, Kevin Baker, Carol Start End Occupation Designation 02/22/ /29/2020 Pediatric Infectious Diseases Specialist Senior Director, Vaccines Biotechnology and Diagnostics Policy, 07/01/ /30/2020 Washington, DC 08/29/ /30/2020 John S. Dunn Clinical Research Professor in Infectious Diseases Professor and Division Director, General Obstetrics and 07/01/ /30/2020 Gynecology 07/01/ /30/2020 Professor of Pediatrics Belongia, Edward 07/01/ /30/2018 Director, Epidemiology Research Center Bennett, Nancy 07/01/ /30/2018 Professor of Medicine and Community and Preventive Medicine Professor of Pediatrics, University of Utah Health Sciences Byington, Carrie 07/01/ /30/2018 Center Coyle, Rebecca 02/01/ /30/2022 Executive Director Deussing, Eric 08/29/ /30/2020 Medical Officer, Department of Defense Ex Officio Duran, Luis Even, Susan Ezeanolue, Echezona 01/26/ /30/2020 Director, Center for Children and Adolescent Health (CeNSIA) 07/01/ /30/2020 Executive Director, Student Health Center, University of Missouri 09/10/ /30/2019 Professor Pediatrics, University of Nevada Immunization Program Manager, VT Dept of Health, Burlington, Finley, Christine 07/01/ /30/2020 VT Professor and Vice Chair, Department of Clinical Pharmacy, Foster, Stephan University of Tennessee Health Sciences Center, College of Pharmacy Clinical Associate Professor of Medicine, Emory University Fryhofer, Sandra 09/15/ /30/2020 School of Medicine Grogg, Stanley Associate Dean/Professor of Pediatrics, Oklahoma State University-Center for Health Sciences Groom, Amy Immunization Program Manager Ex Officio Hahn, Christine State Epidemiologist, Office of Epidemiology, Food Protection and Immunization, Idaho Department of Health and Welfare

5 Hance, Mary Beth Hayes, Carol Hunter, Paul Johnson, David Senior Policy Advisor, Division of Quality, Evaluations and Health Ex Officio Outcomes 01/01/ /30/2020 Planned Parenthood Southeast 08/29/ /30/2020 Assoc Prof of Family Medicine, University of Wisconsin 10/01/ /30/2020 Associate Vice President, Global Medical Affairs Professor of Pediatrics, Director of Primary Care Fellowship, Kempe, Allison 04/17/ /29/2017 Director of Research, Director of Children's Outcomes Research Program Deputy Chief Consultant for Preventive Medicine, National Kim, Jane 12/01/ /30/2020 Center for Health Promotion and Disease Prevention, Durham, NC Ex Officio Professor of Pediatrics, Division of Pediatric Infectious Diseases, Kimberlin, David UAB School of Medicine Lee, Grace Leger, Marie-Michele Lett, Susan McKinney, Paul Associate Chief Medical Officer for Practice Innovation,Lucile 09/01/ /30/2020 Packard Children s Hospital 09/30/ /30/2020 Senior Director, Clinical and Health Affairs 02/08/ /30/2020 MA Dept of Public Health Professor and Associate Dean, University of Louisville School of Public Health and Information Sciences Middleman, Amy Professor of Pediatrics, Chief, Section of Adolescent Medicine Moore, Kelly Nair, Narayan Netoskie, Mark 07/01/ /30/2019 Director, TN Immunization Program, Nashville, TN Division Director/Chief Medical Officer, Health Resources and 01/04/ /30/2020 Services Administration (HRSA) 10/01/ /30/2020 Market Medical Executive, CIGNA PATH, Clinical Professor, Departments of Medicine and Global Neuzil, Kathleen Health, University of Washington School of Medicine O'Leary, Sean Pellegrini, Cynthia 01/04/ /30/2020 Associate Professor of Pediatrics, Children's Hospital, CO 07/01/ /29/2017 Senior Vice President Poland, Gregory 07/01/ /30/2020 Mary Lowell Professor of Medicine and Infectious Diseases Quach, Caroline 06/09/ /30/2021 Pediatric Infectious Disease Specialist Reingold, Arthur 04/16/ /29/2017 Global Health and Infectious Disease, Associate Dean for Riley, Laura Rittle, Charles (Chad) Professor of Epidemiology, Edward Penhoet Distinguished for Research Associate Professor, Obstetrics, Gynecology and Reproductive 07/01/ /30/2018 Medicine 09/01/ /30/2020 Assistant Professor, Nursing Faculty, Chatham University Robertson, Corey 10/01/ /30/2020 Senior Director, Scientific & Medical Affairs, Sanofi Pasteur US Rockwell, Pamela 02/01/ /30/2020 Associate Professor, Dept of Family Medicine Ex Officio

6 Romero, José Savoy, Margot Schaffner, William Schmader, Kenneth 07/01/ /30/2018 Professor of Pediatrics, Pediatric Infectious Diseases Section Medical Director, Dept of Family & Community Med, Wilmington, 07/01/ /30/2020 DE Chairman, Department of Preventative Medicine, Vanderbilt University School of Medicine Professor of Medicine-Geriatrics, Geriatrics Division Chief, Duke 09/30/ /30/2020 University and Durham VA Medical Centers Smith, Nathaniel 02/01/ /30/2022 Director and State Health Officer Stephens, David 09/11/ /30/2019 Professor of Medicine, Emory University, Atlanta, GA Stinchfield, Patricia Sun, Wellington Szilagyi, Peter Thompson, Kimberly Walter, Emmanuel Weber, David Director, Pediatric Infectious Disease and Immunology Infection 09/30/ /30/2020 Control, Children's Hospitals and Clinics of Minnesota Director, Division of Vaccines and Related Product Applications, 09/15/ /30/2020 Ex Officio Office of Vaccines Research and Review, FDA 08/31/ /30/2020 Professor of Pediatrics, UCLA, Los Angeles, CA Professor of Preventive Medicine & Global Health, University of 03/14/ /14/2019 Central Florida, Orlando, FL 09/10/ /30/2019 Professor of Pediatrics, Duke University, Durham, NC Professor of Medicine, Pediatrics and Epidemiology, University 10/01/ /30/2020 of North Carolina Weiser, Thomas 06/01/ /30/2022 Medical Epidemiologist Wharton, Melinda 10/25/ /03/2019 CDC Whitley-Williams, Patricia Zahn, Matthew Ex Officio Ex Officio Professor and Interim Chair, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School Medical Director, Epidemiology, Orange County Health Care 09/15/ /30/2020 Agency Number of Committee s Listed: 60 Charter Dates Report Charter Date Committee Number Committee Name Fiscal Year 04/01/ Advisory Committee on Immunization Practices /01/ Advisory Committee on Immunization Practices /01/ Advisory Committee on Immunization Practices /01/ Advisory Committee on Immunization Practices /01/ Advisory Committee on Immunization Practices /01/ Advisory Committee on Immunization Practices /01/ Advisory Committee on Immunization Practices /01/ Advisory Committee on Immunization Practices /01/ Advisory Committee on Immunization Practices /03/ Advisory Committee on Immunization Practices /01/ Advisory Committee on Immunization Practices /01/ Advisory Committee on Immunization Practices /01/ Advisory Committee on Immunization Practices /01/ Advisory Committee on Immunization Practices 1992

7 What are the most significant program outcomes associated with these committee(s)? Yes % Improvements to health or safety Trust in government Major policy changes Advance in scientific research 0 0 Effective grant making 0 0 Improved service delivery 0 0 Increased customer satisfaction 0 0 Implementation of laws or regulatory requirements 0 0 Other 0 0 What are the cost savings associated with these committee(s)? None 1 Unable to Determine 0 Under $100,000 0 $100,000 - $500,000 0 $500,001 - $1,000,000 0 $1,000,001 - $5,000,000 0 $5,000,001 - $10,000,000 0 Over $10,000,000 0 Cost Savings Other 0 What is the approximate Number of recommendations produced by these committee(s) for the life of the committee(s)? 227 Total What is the approximate Percentage of these recommendations that have been or will be Fully implemented by the agency? 100% What is the approximate Percentage of these recommendations that have been or will be Partially implemented by the agency? 0% Does the agency provide the committee with feedback regarding actions taken to implement recommendations or advice offered?

8 Yes: 1 No: 0 Not Applicable: 0 What other actions has the agency taken as a result of the committees advice or recommendation? Yes % Reorganized Prioririties Reallocated resources Issued new regulation Proposed legislation 0 0 Approved grants or other payments 0 0 Other 0 0 Are the Committee(s) engaged in the review of applications for grants? Yes % Engaged in grants 0 0 if answer is Yes What is the estimated What is the estimated What is the estimated Number of grants reviewed for approval 0 Number of grants recommended for approval 0 Dollar Value of grants recommended for approval $0 How is access provided to the information for the Committees documentation? Yes % Contact DFO Online Agency Web Site Online Committee Web Site Online GSA FACA Web Site Publications Other 0 0